Demo Sign up Log In

Cartesian Therapeutics Inc (RNAC)

Cash Conversion Ratio

0.57×

Quarterly · Period ending: Mar 31, 2026

RNAC Cash Conversion Ratio

Latest reported0.57×period endingMar 31, 2026

Latest reported0.57×period endingMar 31, 2026

RNAC Quarterly Cash Conversion Ratio (0.88× → 0.57×)

Latest values, visible window

High-resolution chart · PNG

RNAC cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Mar 31, 2026	0.5656×
Dec 31, 2025	0.1966×
Sep 30, 2025	0.4705×
Jun 30, 2025	-1.2663×
Mar 31, 2025	1.3655×
Dec 31, 2024	0.7517×
Sep 30, 2024	-0.3098×
Jun 30, 2024	-1.1588×
Mar 31, 2024	0.2907×
Dec 31, 2023	0.1314×
Sep 30, 2023	1.0237×
Jun 30, 2023	0.87×
Mar 31, 2023	0.4106×
Dec 31, 2022	-2.0465×
Sep 30, 2022	-0.4963×
Jun 30, 2022	-1.4382×
Mar 31, 2022	-0.4281×
Dec 31, 2021	-2.5932×
Sep 30, 2021	0.6097×
Jun 30, 2021	-1.4591×
Mar 31, 2021	0.4943×
Dec 31, 2020	0.4817×
Sep 30, 2020	-6.7166×
Dec 31, 2019	0.8673×
Jun 30, 2019	0.4393×
Mar 31, 2019	1.6763×
Dec 31, 2018	0.8952×
Dec 31, 2017	0.656×
Sep 30, 2017	1.0602×
Jun 30, 2017	0.5646×
Mar 31, 2017	1.0159×
Dec 31, 2016	-0.1028×
Sep 30, 2016	0.743×
Jun 30, 2016	0.8184×
Mar 31, 2016	1.3789×
Dec 31, 2015	1.1348×
Sep 30, 2015	1.0638×
Jun 30, 2015	0.6907×
Mar 31, 2015	0.8758×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.